Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low Cmax and improved tolerability, in patients with solid tumors
Ajani, Jaffer A., Javle, Milind, Eng, Cathy, Fogelman, David, Smith, Jackie, Anderson, Barry, Zhang, Chun, Iizuka, KenzoJournal:
Investigational New Drugs
DOI:
10.1007/s10637-020-00939-w
Date:
May, 2020
File:
PDF, 645 KB
2020
File converter
More search results
More benefits 
